Author:
Miller Gary W.,Gainetdinov Raul R.,Caron Marc G.
Reference115 articles.
1. Backman, L., Robins-Wahlin, T. B., Lundin, A., Ginovart, N., Farde, L. (1997). Cognitive deficits in Huntington’s disease are predicted by dopaminergic PET markers and brain volumes. Brain 120, 2207–17.
2. Barrickman, L., Noyes, R., Kuperman, S., Schumacher, E., Verda, M. (1991). Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 30, 762–7.
3. Ben-Shachar, D., Zuk, R., Glinka, Y. (1995). Dopamine neurotoxicity: inhibition of mitochondrial respiration. J Neurochem 64, 718–23.
4. Blakely, R. D., Berson, H. E., Fremeau, R. T., Jr., Caron, M. G., Peek, M. M., Prince, H. K., Bradley, C. C. (1991). Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66–70.
5. Blum, K., Braverman, E. R., Wu, S., Cull, J. G., Chen, T. J., Gill, J., Wood, R., Eisenberg, A., Sherman, M., Davis, K. R., Matthews, D., Fischer, L., Schnautz, N., Walsh, W., Pontius, A. A., Zedar, M., Kaats, G., Comings, D. E. (1997). Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry 2, 239–46.